CRLComplete Response Letter
Complete Response Letter Roxane Laboratories, Inc. (May 3, 2013)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Chemistry, manufacturing, and controls. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
Issued
US FDA• CYCLOPHOSPHAMIDE
